Botanical species · safety record

Artocarpus altilis

The EFSA Compendium of Botanicals holds 6 constituent measurements and 1 adverse-effect record for Artocarpus altilis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Artocarpus altilis (Parkinson ex F.A.Zorn) Fosberg

6Constituent measurements

1Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Anthraquinones	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Furan derivatives	Leaves	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Saponins	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Artocarpin	Wood	Solvent extraction	≤ 371 Milligram/gram	HPLC-UV	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Liver	Aerial part of plants	Solvent extraction	Rat (as animal)	Short-term toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Coe, F.G., Parikh, D.M., Johnson, C.A., Anderson, G.J. The good and the bad: Alkaloid screening and brineshrimp bioassays of aqueous extracts of 31 medicinal plants of eastern Nicaragua. Pharmaceutical Biology, 2012, vol. 50, no. 3, p. 384-392. DOI
Siddesha, Jalahalli M., Angaswamy, Nataraju., Vishwanath, Bannikuppe S. Phytochemical screening and evaluation of in vitro angiotensin-converting enzyme inhibitory activity of Artocarpus altilis leaf. NATURAL PRODUCT RESEARCH, 2011, vol. 25, no. 20, p. 1931-1940. DOI
Sairam, Sudha., Urooj, Asna. Safety Evaluation of Artocarpus altilis as Pharmaceutical Agent in Wistar Rats. . Journal of toxicology, 2014, vol. 2014, p. 980404-980404. DOI
Nguyen Thi Thanh Mai., Nguyen Xuan Hai., Dang Hoang Phu., Phan Nguyen Huu Trong., Nguyen Trung Nhan. Three new geranyl aurones from the leaves of Artocarpus altilis. Phytochemistry letters, 2012, vol. 5, no. 3, p. 647-650. DOI
Tzeng, Cheng-Wei., Yen, Feng-Lin., Lin, Liang-Tzung., Lee, Chiang-Wen., Yen, Ming-Hong., Tzeng, Wen-Sheng., Lin, Chun-Ching. Antihepatoma activity of Artocarpus communis is higher in fractions with high artocarpin content. Thescientificworldjournal, 2014, vol. 2014, p. 978525.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature